Cargando…
The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
BACKGROUND: There is a lack of studies focusing on the benefit of liver transplantation (LT) in hepatocellular carcinoma (HCC) patients with > 3 tumors. This study aims to establish a model to effectively predict overall survival in Chinese HCC patients with multiple tumors (> 3 tumors) who un...
Autores principales: | Wang, Jingrui, Bao, Jiaqi, Wang, Rui, Hong, Jiachen, Zhang, Lincheng, Que, Qingyang, Xu, Shengjun, Wu, Yongfeng, Zhan, Qifan, Liu, Yuchen, Liu, Jimin, Zheng, Shusen, Ling, Sunbin, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041809/ https://www.ncbi.nlm.nih.gov/pubmed/36967432 http://dx.doi.org/10.1186/s12957-023-02994-y |
Ejemplares similares
-
Ubiquitin‐specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma
por: Ye, Qianwei, et al.
Publicado: (2023) -
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma
por: Yu, Jiongjie, et al.
Publicado: (2023) -
Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
por: Xu, Shengjun, et al.
Publicado: (2021) -
Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023) -
Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)